Obesity is a well-established cause of postmenopausal breast cancer. However, early life adiposity is inversely associated with breast cancer incidence. To understand these conflicting relations, we use validated measures to assess adiposity in childhood and late adolescence, as well as weight change, in relation to total invasive breast cancer incidence and receptor subtypes. We conducted a prospective observational study among 74,177 women from the Nurses' Health Study from 1980-2012, with updated risk factors every 2 years during which 4,965 incident invasive breast cancers occurred. Overall, weight at age 18 was inversely associated with both premenopausal (HR per 30 kg 5 0.52, 95% CI 5 0.39-0.71) and postmenopausal (HR per 30 kg 5 0.81, 95% CI 5 0.72-0.92) breast cancer which was largely explained by adiposity at age 10. Long-term weight gain from age 18 both during premenopause and postmenopause were positively associated with postmenopausal breast cancer risk. However, premenopausal weight gain was not related to premenopausal breast cancer risk. Obesity is well established as a cause of postmenopausal breast cancer incidence and mortality.
Obesity is well established as a cause of postmenopausal breast cancer incidence and mortality. 1, 2 In contrast, adiposity from early life through premenopausal years is inversely associated with breast cancer incidence. 3, 4 This is most clearly observed for adiposity at ages 5 and 10. 4 However, studies using measures of adiposity at age 18 also report inverse relations with premenopausal breast cancer 5 and for some, but not all, subtypes of breast cancer defined by molecular status. 6 Early life adiposity may impact growth and maturation. Childhood adiposity is related to earlier age at menarche and lower height growth velocity, 7, 8 but does not impact final attained height, 7 and is potentially related to other intermediate markers of breast cancer risk such as benign breast disease 9 and breast density. 10, 11 Mechanisms for the inverse association have been explored and include alterations in clonal pools, endogenous hormone levels 12, 13 across pre and postmenopausal years, and breast density. 10 Prospective Nurses' Health Study (NHS) data show weight loss after menopause is related to reduced breast cancer incidence, 14 consistent with reduced risk of breast cancer among women after bariatric surgery. 15 However, the temporal relation between childhood and adolescent weight, weight gain (both before and after menopause), and risk of pre and postmenopausal breast cancer is not well defined. The validated Rosner-Colditz model of breast cancer incidence evaluates risk factors across the life-course, integrating exposures and The Nurses' Health Study cohort was established in 1976 when 121,701 female US registered nurses ages 30-55 responded to a mail questionnaire inquiring about risk factors for breast cancer including reproductive factors, hormone therapy use (HT), anthropometric variables, benign breast disease (BBD), and family history of breast cancer. The risk factors have been updated by repeat questionnaires obtained every 2 years up to the present time. 18 Current alcohol consumption was ascertained in 1980, updated in 1984, and then every 4 years from 1986 to 2010. Alcohol consumption at age 18 was assessed in 1988. Weight at age 18 was ascertained in 1980. In addition, we excluded women with type of menopause other than natural or bilateral oophorectomy, prevalent cancer (other than non-melanoma skin cancer) in 1980, or missing data for weight at age 18, age at first birth, parity, age at menarche, age at menopause or hormone use.
Identification of breast cancer cases
On each questionnaire, women were asked whether breast cancer had been diagnosed, and if so, the date of diagnosis. All women (or the next of kin, if deceased) were contacted for permission to review medical records to confirm the diagnosis. Pathology reports were reviewed to obtain information on estrogen receptor (ER) and progesterone receptor (PR). Cases of invasive breast cancer from 1980-2012 were included in the primary analysis. Thus, overall, 74,177 women were followed over 1,595,695 person-years from 1980-2012 during which 4,965 incident invasive cases of breast cancer occurred and are used for the primary analysis. A total of 2,412 ER1/ PR1 tumors, 662 ER2/PR2 tumors, and 598 ER1/PR2 tumors were identified. For subtype analyses, 1,293 breast cancer cases with missing ER and/or PR status were censored at the time of diagnosis.
Weight and height measures
Adult weight was reported every two years on follow-up questionnaires. Weight at age 18 was recalled in 1980, the beginning of the follow-up for this analysis. Adult height was reported at entry to the cohort. Adult weights for participants who were missing at a specific questionnaire were carried forward from the previous questionnaires for 1 questionnaire cycle (i.e., 2 years) and after that were considered missing. We defined the categories of weight change since age 18 as >5 kg. weight loss ( weight change status as of 1994, the approximate midpoint of follow-up. In our analyses, weight change since age 18 was updated at each questionnaire cycle (i.e., every 2 years). Validity of self-reported weight in this cohort was shown to be strongly related to measured weight (r 5 0.97) 19 with mean difference of self-reported weight and measured weight 6 to 12 months later being 1.5 kg higher. 19 Validity of recalled weight at age 18 was assessed in younger nurses and compared against nursing school admission physical exam records (mean difference between self-report and recorded weights of 1.4 kg; correlation of 0.87 independent of current age). 20 Adiposity at age 10 in NHS was assessed in 1988 by the validated Stunkard body figure diagram (range 1-9). 21 
Statistical methods
The log-incidence model of breast cancer. We use the logincidence model to summarize major risk factors across the life course. Details concerning the model have been provided previously. 16, 17, 22 The parameters of the model include (i) duration of premenopause, (ii) duration postmenopause, (iii) type of menopause, natural or surgical (iv) parity and age at each birth, (v) current, past hormone therapy (HT) use, (vi) duration of HT use by type (estrogen only vs. estrogen plus progestin E&P), (vii) adult height, (viii) benign breast disease (BBD), (ix) alcohol intake, (x) family history of breast cancer in a first degree relative. We subdivide current weight (at time t) into components as follows:
What's new? Obesity after menopause has long been thought to increase the risk of breast cancer. In this analysis of data from a large, prospective study, the authors found that weight gain either before or after menopause is associated with an increased risk of postmenopausal, ER1/PR1 breast cancer. The authors also calculated that excess weight gain accounts for 14% of all postmenopausal breast cancers in this cohort. These results support public-health initiatives to enhance weight control throughout adulthood, in order to reduce a woman's risk of postmenopausal breast cancer.
weight at time t 5 weight at age 18 (1) is that each of the components is only weakly correlated (Appendix A1), thus reducing collinearity, whereas (somatotype at age 10, weight at age 18, weight at menopause, current weight) are moderately to strongly correlated (Appendix Table A2 ). These analyses were performed both for overall breast cancer, and separately by menopausal status. Interaction tests were also performed to compare hazard ratios (HR) for weight gain since age 18 for premenopausal versus postmenopausal breast cancer. Furthermore, additional analyses were also performed by tumor subtype (ER1/PR1, ER1/ PR2 and ER2/PR2) and heterogeneity tests were performed to compare HRs for weight gain since age 18 for ER1/PR1 tumors versus each of ER1/PR2 and ER2/PR2 tumors, respectively, both for overall as well as postmenopausal breast cancer. 23 Because duration in years for weight gain from age 18 to menopause is longer than the interval from menopause to current age, we repeated analyses using categories of weight gain per year (Appendix Table A5 ). In addition, comparisons were made of HR for premenopausal versus postmenopausal weight gain and weight gain/yr for postmenopausal breast cancer. We also computed the attributable risk (AR) if all postmenopausal women who gained > 5 kg of weight since age 18 did not change their weight (i.e., weight gain or loss of 5 kg) using the formula 
Results

Risk factors by weight change status
At the midpoint of follow-up (1994) the established risk factors for breast cancer varied modestly across categories of weight change (see Table 1 ). Women with weight loss were older and heavier at age 18 and had a heavier somatotype at age 10. Parity was positively related to weight gain category (mean of 2.7 children for women who lost weight vs. 3.1 for those with extreme weight gain). Alcohol intake was inversely related to weight gain category, and duration of estrogen use was shorter among women with more weight gain. Four percent of women lost >5 kg from age 18 to 1994; 21% of women maintained their weight at age 18 (within 5 kg of their weight at age 18); 27% of women gained 20 kg from their weight at age 18.
Correlation among weight measures
Correlations among somatotype at age 10, weight measures and weight change measures are summarized in Tables A1  and A2 . Among postmenopausal women, somatotype at age 10 has a low correlation with (i) weight change during premenopause (r 5 20.11), (ii) weight change/year during premenopause (r 5 20.11), (iii) weight change during postmenopause (r 5 20.04) and (iv) weight change/year during postmenopause (r 5 20.00). Also, weight change during premenopause is only weakly correlated with weight change during postmenopause (r 5 20.00) and weight change/year during premenopause is weakly correlated with weight change/year during postmenopause (r 5 0.09). Similarly, among premenopausal women, somatotype at age 10 is only weakly correlated with both weight change during premenopause (r 5 0.01) and weight change/year during premenopause (r 5 0.01). Finally, there were strong correlations between weight change and weight change/year for both premenopausal and postmenopausal women. For postmenopausal women, somatotype was moderately correlated with weight at age 18 (r 5 0.45) and weakly correlated with weight at menopause (r 5 0.22) and weight in 1994 (r 5 0.18). Weight at age 18 was moderately correlated with weight at menopause (r 5 0.56) and with weight in 1994 (r 5 0.48); similarly, weight at menopause was strongly correlated with weight in 1994 (r 5 0.86; Appendix Table A2 ). Similar correlations were seen for premenopausal women.
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Long-term weight change from age 18 and breast cancer incidence Table 2 reports the mean weight at age 18 and standard deviation (SD), and mean weight change (with the 10% and 90% percentiles) for each analysis. Overall, mean weight at age 18 was 57.4 kg and mean weight change was 12.1 kg. We first fit a model with weight at age 18 and change from 18 to current age after controlling for standard breast cancer risk factors. Overall, weight at age 18 was inversely related to risk of breast cancer; the hazard ratio (HR) per 30 kg difference at Cancer Epidemiology Cancer Epidemiology 
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Examining risk separately for premenopausal women, we observed a persistent reduction in risk with greater weight at age 18 (HR per 30 kg 5 0.52, 95% CI 5 0.39-0.71). There was no overall increase in premenopausal breast cancer risk with premenopausal weight gain (HR per 30 kg weight change 5 1.02, 95% CI 5 0.93-1.12). Among postmenopausal women, weight at age 18 remained significantly inversely related to risk (HR per 30 kg 5 0.81, 95% CI 5 0.72-0.92). In contrast, weight gain from age 18 was significantly related to incidence of postmenopausal breast cancer (HR 5 1.37, 95% CI 5 1.26-1.50) for weight gain of 20 kg or more from age 18 compared to stable weight. There was a significant interaction of the effect of weight gain since age 18 by menopausal status (HR per 30 kg 5 1.02 pre vs. 1.37 post, p_het_1 5 0.028). For postmenopausal women, when we separated weight gain since age 18 into change during premenopausal years (HR per 30 kg 51.35, 95% CI 5 1.24-1.48) and weight gain after menopause (HR per 30 kg 5 1.40, 95% CI 5 1.24-1.58), and adjusted for each simultaneously, the hazard ratios were not significantly different (p_het_2 5 0.63), indicating weight gain during both premenopausal and postmenopausal years was associated with increased risk of postmenopausal breast cancer with equal slope per kg of weight gain (Table 2) .
We next assessed the association of breast cancer incidence with long-term weight change from age 18 after controlling for somatotype at age 10 (Table 3 ). Somatotype at age 10 was inversely related to risk (HR per 4 unit increase in somatotype 5 0.78, 95% CI 5 0.70-0.86), but weight at age 18 was no longer significantly related to breast cancer risk (HR per 30 kg 5 0.95, 95% CI 5 0.82-1.09). After controlling for somatotype at age 10 and weight at age 18, weight loss of >5 kg from age 18 remained significantly inversely associated with overall breast cancer risk (HR 5 0.74, 95% CI 5 0.61-0.89) and weight change from age 18 remained significantly positively associated with overall breast cancer risk (HR per 30 kg increase 51.31, 95% CI 5 1.22-1.41). Results for weight gain during pre and postmenopausal years and postmenopausal breast cancer remained largely unchanged when mutually adjusted for; premenopausal weight change (HR per 30 kg 51.36, 95% CI 5 1.24-1.50); postmenopausal weight change (HR per 30 kg 5 1.37, 95% CI 5 1.20-1.55). Because this primary analysis of somatotype at age 10 included pictograms recalled after women were diagnosed with breast cancer we repeated the analysis limiting follow-up to the interval 1988 to 2012 and results were unchanged (Appendix Table  A3 ).
Tumor characteristics
We next assessed weight gain and cancer defined by receptor status in the 3,672 cases with these data, and evaluated associations overall and among postmenopausal women (Table  4) . For the 2,412 incident cases of ER1/PR1 breast cancer, weight gain after 18 showed an overall positive association (HR per 30 kg weight change 51.41, 95% CI 5 1.29-1.55). Weight at age 18 was not significantly related to risk of ER1/PR1 breast cancer (HR per 30 kg 5 0.94, 95% CI 5 0.80-1.11). Among postmenopausal women weight gain since 18 was strongly related to increased risk (HR 51.50 per 30 kg weight gain, 95% CI 5 1.36-1.65). This result persisted for weight gain before and after menopause, (HR per 30 kg weight change before menopause 5 1.49, 95% CI 5 1.32-1.68 and HR per 30 kg weight change after menopause 5 1.52, 95% CI 5 1.29-1.79).
For ER1/PR2 tumors the overall association for weight at age 18 was significantly inverse (HR per 30 kg 5 0.65, 95% We repeated analyses from Table 4 adding somatotype at age 10 (Appendix Table A4 ). Somatotype at age 10 was significantly inversely related to risk of ER1/PR1 tumors overall (HR per 4 unit increase in somatotype 5 0.77, 95% CI 5 0.67-0.89). For ER1/PR2 the association was not significant, and for ER2/PR2 tumors the association was significantly inverse for somatotype at age 10; HR per 4 unit increase in somatotype 5 0.73, 95% CI 5 0.55-0.98). Results for weight change since age 18 by receptor status were similar to Table 4 . Because intervals for weight gain vary with follow-up and weight gain over premenopausal years spans over 30 years while postmenopause is shorter, on average, we repeated analyses using categories of weight gain per year (Appendix Table A5 ). We see that there are significant associations between wt change/yr and overall incidence of breast cancer (HR per 0.75 kg wt change/yr 5 1.27, 95% CI 5 1.19-1.93, p < 0.001). When stratified by menopausal status, there were significant effects for postmenopausal (HR 5 1.36 per 0.75 kg wt change/yr, 95% CI 5 1.26-1.48, p < 0.001), but not premenopausal breast cancer (HR 5 1.05 per 0.75 kg wt change/yr, 95% CI 5 0.92-1.21, p 5 0.48) which were significantly different (p_het_1 5 0.003). Furthermore, for postmenopausal breast cancer, there were significant effects of weight change/year both during premenopause and postmenopause when mutually adjusted for each other (p < 0.0001). However, the effect of weight change/yr was significantly stronger during premenopause (HR 5 1.27 per 0.75 kg/yr, 95% CI 5 1.18-1.36) than during postmenopause (HR 5 1.07 per 0.75 kg/yr, 95% CI 5 1.04-1.09) (p_het_2 < 0.0001). But this may be due to the longer duration of premenopause versus postmenopause among NHS women since the HR per kg weight change were not significantly different between these two time periods (see Table 2 ). Thus, the causal risk factor may be weight change rather than weight change/year.
Finally, we estimated the AR if postmenopausal women who gained > 5 kg of weight since age 18 had not changed their weight by >5 kg (i.e., weight gain or loss since age 18 5 kg). The results are presented in Table 5 . We see that approximately 75% of postmenopausal women gained 5 kg since age 18, 21% maintained their weight (gain or loss 5 kg) and 4% of women lost weight (> 5 kg). The AR for overall postmenopausal breast cancer was 14% and for ER1/PR1 breast cancer was 17%.
Discussion
In these detailed prospective analyses of weight change across the life-course, after controlling for 10 established breast cancer risk factors, adiposity at age 10 was inversely related to risk of pre and postmenopausal breast cancer,. Weight loss of >5 kg after age 18 was inversely related to risk of postmenopausal breast cancer. Weight gain after 18 was associated with increased risk of postmenopausal breast cancer-and the timing of weight gain either before or after menopause did not modify risk. Women who gained weight in premenopausal years were at increased risk of postmenopausal breast cancer compared to those whose weight remained stable, as were women who gained weight after menopause, when weight change during each period was entered into the model simultaneously. To inform possible mechanisms, we also evaluated associations with breast cancer classified by receptor status. Weight gain from age 18 was most clearly related to ER1/PR1 breast cancer in postmenopausal women. Indeed the AR of weight gain of > 5 kg since age 18 compared to maintaining a stable weight ( 5 kg gain or loss) for ER1/PR1 postmenopausal breast cancer was 17%. However, long-term weight gain in premenopausal years was not related to risk of premenopausal breast cancer.
These data confirm prospective studies relating weight gain and adiposity to risk of postmenopausal breast cancer, 24, 25 and to ER1 breast cancer, 26 consistent with endogenous hormones and risk of total breast cancer 27 and more directly ER1 breast cancer. 28 Importantly, they add new insights on weight gain during premenopausal years and risk of postmenopausal breast cancer. This area has had more limited investigation; previously combined data among premenopausal women typically ignore weight at age 18 or earlier weight, that we show is highly correlated with premenopausal weight. 4 In fact, the inverse associations for weight at age 18 are largely explained by somatotype at age 10. Furthermore, after controlling for somatotype at age 10 and weight at age 18, weight change in both pre and postmenopausal years is related to significantly increased risk of postmenopausal breast cancer. Previously, data from Nurses' Health Study II showed borderline significant reductions in risk of premenopausal breast cancer with weight loss after age 18. 29 Together these data support public health approaches to enhance weight control through premenopausal years to reduce risk of postmenopausal breast cancer.
A report from Mexico using trajectories of weight gain showed increasing adiposity from age 8 was related to increased risk. 30 However, once we control for somatotype at age 10, and weight at age 18, weight gain during both premenopausal and postmenopausal years is related to increased risk of postmenopausal breast cancer, while adiposity at age 10 has a strong sustained inverse relation to risk. However, the increased risk of weight gain since age 18 is limited to ER1/PR1 postmenopausal breast cancer, while the inverse association with weight at age 18 is limited to ER1/PR2 and ER2/PR2 postmenopausal breast cancer. In contrast, the French E3N cohort shows adiposity at ages 8 through 25 is inversely related to postmenopausal ER1 PR1 but not ER2PR2 breast cancer. 31 Weight in this cohort is self-reported but validation studies show it is highly correlated with independently measured weight 19 and the mean difference between self-reported and measured weight is minimal. Recalled childhood adiposity at age 10 using the Stunkard pictograms has been validated. 21 Recalled weight at age 18 is reproducible and has little bias. 20 Our analytic approach is a strength controlling for reproductive risk factors, alcohol, family history and BBD. After controlling for these potential confounders of weight change and adult weight we note that our overall population attributable risk is comparable to that reported by Arnold for postmenopausal US women using baseline BMI and a reference of BMI of 22 kg/m 2 . 32 We extend on that work estimating that 17% of ER1/PR1 breast cancer is attributable to weight gain of >5 kg after age 18.
Remaining unanswered questions from these data relate to mechanisms for early life adiposity to impact risk. Such pathways may include breast density (recent European data 10 ) and growth velocity that is inversely related to childhood adiposity, 7 and itself is independently related to risk of pre and postmenopausal breast cancer. 8, 33, 34 In conclusion, adiposity in childhood and at age 18 has a protective lifelong relation to breast cancer risk most clearly seen for ER2/PR2 disease. But there are adverse effects of long-term adult weight gain both before and after menopause for postmenopausal but not premenopausal breast cancer. This relation is most clearly seen for ER1/PR1 postmenopausal breast cancer, supporting mechanisms mediated through circulating estrogens. 35 Weight change can importantly modify breast cancer risk but the association varies during the life course. Maintaining weight throughout life has strong benefits in avoiding increases in breast cancer risk, as well as multiple other major chronic diseases.
Furthermore, the weak correlation in Appendix Table A1 between weight change premenopause versus weight change postmenopause (r 5 20.00) and between weight change/year premenopause versus weight change/year postmenopause (r 5 0.09) has implications for targeted public health advice since avoidance of weight gain in either time period is associated with reduced postmenopausal breast cancer incidence.
